4//SEC Filing
FERRARI LOUIS 4
Accession 0001181431-12-060647
CIK 0000722104other
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 4:12 PM ET
Size
9.3 KB
Accession
0001181431-12-060647
Insider Transaction Report
Form 4
FERRARI LOUIS
SVP, North American Commerical
Transactions
- Award
Common Stock, $.01 par value per share
2012-02-29$1.71/sh+2,622$4,480→ 351,199 total - Award
Common Stock, $.01 par value per share
2012-08-31$1.12/sh+2,434$2,731→ 359,521 total - Award
Common Stock, $.01 par value per share
2012-05-31$0.62/sh+5,888$3,625→ 357,087 total - Sale
Common Stock, $.01 par value per share
2012-11-26$1.16/sh−950$1,102→ 358,571 total
Footnotes (2)
- [F1]Consists of shares acquired pursuant to the Savient Pharmaceuticals, Inc. 1998 Employee Stock Purchase Plan, which were not previously reported on a Form 4.
- [F2]These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 21, 2011.
Documents
Issuer
SAVIENT PHARMACEUTICALS INC
CIK 0000722104
Entity typeother
Related Parties
1- filerCIK 0001513697
Filing Metadata
- Form type
- 4
- Filed
- Nov 26, 7:00 PM ET
- Accepted
- Nov 27, 4:12 PM ET
- Size
- 9.3 KB